Atorvastatin Calcium
Product Images NDC 70934-250

5 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70934-250). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (70934 250 90 Rev A 01 19)

Label (70934 250 90 Rev A 01 19)
Atorvastatin Calcium Tablets 10 mg packaging label featuring a 90-tablet bottle. The label includes dosage instructions as prescription use only, storage conditions, and manufacturer information, Denton Pharma, Inc. DBA Northwind Pharmaceuticals. NDC 70934-250.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line graph depicting cumulative incidence percentages over a period of 3.5 years comparing Atorvastatin and placebo groups. The solid line represents Atorvastatin, showing a lower incidence than the dashed line for placebo. The graph includes a hazard ratio (HR) with confidence interval and a p-value indicating statistical significance.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line graph showing cumulative hazard (%) over time (years) comparing Atorvastatin treatment vs. Placebo. The X-axis represents time to first primary endpoint through four years of follow-up, and the Y-axis shows cumulative hazard percentage. Atorvastatin's hazard is consistently lower than placebo, with hazard ratio (HR) 0.63 (0.48-0.83), p=0.001 indicated on the graph.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time between Atorvastatin 10 mg and Atorvastatin 80 mg. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. A hazard ratio (HR) with confidence interval and p-value is noted on the graph.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of atorvastatin calcium, showing its molecular arrangement including the calcium ion (Ca 2+) complex. The diagram represents two atorvastatin molecules coordinated with calcium.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.